Edgen Stock·Dec 18 2025, 13:04Back
Pfizer/Astellas Cancer Therapy Improves Bladder Cancer Survival
Edgen Stock·Dec 18 2025, 13:04
[1] PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility - Pfizer (https://www.pfizer.com/news/press-release/pre ...)
